Future Science OA (Sep 2021)

ABO phenotype and clinical correlates of COVID-19 severity in hospitalized patients

  • David J Hermel,
  • Samantha R Spierling Bagsic,
  • Carrie L Costantini,
  • James R Mason,
  • Zhubin J Gahvari,
  • Alan Saven

DOI
https://doi.org/10.2144/fsoa-2021-0045
Journal volume & issue
Vol. 7, no. 8

Abstract

Read online

Aim: This study investigates the association between ABO blood phenotype and COVID-19 severity, measured by intensive care unit admission, need for intubation, hospitalization length and death. It further explores clinical predictors of COVID-19 severity within a primarily Hispanic demographic in San Diego County. Materials & methods: We retrospectively reviewed 942 total patients, 473 with available blood type, hospitalized at five Scripps Health hospitals with COVID-19. Results: No significant association was found between ABO phenotype and COVID-19 severity on multivariate analysis, while a diagnosis of anemia and male sex was associated with all severity outcomes on exploratory analysis. Conclusion: Our results provide relevant clinical correlates of COVID-19 severity and help better elucidate the association between ABO phenotype and COVID-19.

Keywords